Abstract
In recent years, large-scale studies based on data from administrative databases have reported changes in diabetes incidence over time. Different countries show various trends: stable incidence, decreases, and increases. High-income countries have seen a decline in diabetes incidence, possibly linked to changes in diagnosis and screening practices. The number of children and adolescents with diabetes, particularly type 2, is increasing, significantly impacting society. Diabetes is a cause of premature mortality and disability, negatively affecting the economy. In the USA, premature mortality is estimated to cost 19.9 billion dollars annually. In Kyrgyzstan, the burden of non-communicable diseases, including type 2 diabetes, is growing. Measures to combat diabetes in the country include free provision of insulin and medications, the approval of clinical guidelines and protocols, and the implementation of national prevention and control programs. The State Guarantee Program ensures free medication assistance for diabetes patients. Despite these efforts, issues with funding and resource efficiency remain. Improving the quality of medical care, intersectoral cooperation, and increasing accountability for public health are necessary. Enhancing the quality of pharmaceutical care and the efficient use of public funds are also priorities for improving the diabetes situation in Kyrgyzstan. Early diagnosis and treatment of diabetes complications, as well as the implementation of new prevention strategies, are crucial for reducing incidence and improving the quality of life for patients.
Publisher
Publishing Center Science and Practice